Athletics confronts the fallout from Ruth Chepngetich’s record and later failed test
On 13 October 2026, athletics officials continued to grapple with the consequences of Ruth Chepngetich’s failed doping test, which occurred five months after she broke the women’s marathon world record in Chicago in 2024.
When Chepngetich crossed the line in 2hr 9min 56sec in Chicago, NBC commentators compared the performance to the moon landing—one saying “Bring it on Neil Armstrong!”, another that “She has done things in this sport that we have not seen,” and a third calling it “Unbelievable!” The run lowered the world record by 1min 57sec and improved her personal best by five minutes; asked about suspicions afterwards by Robert Johnson of Let’s Run she replied, “People must talk,” and added, “I don't know.” Five months later she failed a doping test and was subsequently banned for three years.
Brett Clothier, head of the Athletics Integrity Unit, told the author that the situation “is not satisfactory, to be frank,” while noting the world anti-doping code protects athletes’ rights when results at the time of a performance are negative. Chepngetich’s world record remains on the books because she passed a test immediately after the Chicago race, a circumstance Clothier and the AIU say limits what the sport can do under current rules.
The AIU’s case record shows Chepngetich tested at 20 times the legal limit for hydrochlorothiazide (HCTZ); her explanation that she had taken her housemaid’s medication after feeling hot and having a rapid resting heartbeat was described by the AIU as a “hardly credible” explanation. Investigators also reported finding screenshots on her phone referring to the banned drug testosterone and “messages related to unidentified third parties working on ‘programs’ possibly related to doping.” Chepngetich has denied using testosterone and said the messages came from a group chat.
Wada told the author that removing earlier results “in the absence of any evidence or reasonable inference that the athlete was doping before or at the time of the earlier results, might well breach a number of legal principles including proportionality and human rights.” The agency rejected the Lance Armstrong precedent as broadly applicable, saying, “He had procedural avenues open to him to contest the sanction but ultimately chose not to use them,” and adding, “That makes his case a relatively weak precedent for establishing how far retrospective disqualification could legally go.”
One proposal discussed was a social contract under which athletes would agree to forfeit records or medals if they tested positive within a defined period after a result; an anti-doping expert said such an approach was “in theory” possible but would require unanimous agreement across federations, governments, athlete bodies and human rights groups and a change to the Wada code, a course the expert judged unlikely.
The AIU cites measurable enforcement outcomes: it has sanctioned 317 elite Kenyan athletes since its 2017 inception and operates on a budget of $11.9m (£9m) a year. Sponsors have also funded extra testing in recent high-profile cases—Adidas paid $50,000 for additional testing before Sabastian Sawe’s men’s marathon world record in London, and Nike arranged extra tests for Jacob Kiplimo and Brigid Kosgei before Chicago—while agent Eric Lilot has proposed contracts requiring athletes to relinquish money if shown to have intentionally doped.
Those added testing measures and contractual proposals, the author notes, “point to brighter days ahead,” however much Chepngetich’s record continues to make people in the sport uneasy.